Related Experiment Video

Updated: Aug 7, 2025

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.5K

Chinese expert consensus on antithrombotic management of high-risk elderly patients with chronic coronary syndrome

Cuntai Zhang1, Xiaoming Wang2,

  • 1Department of Geriatrics, Tongji Hospital, Tongji Medical College Huazhong University of Science & Technology Wuhan China.

Aging Medicine (Milton (N.S.W))
|March 13, 2023
PubMed

Insights

This consensus provides guidance on antithrombotic treatment for elderly patients with high-risk chronic coronary syndrome (CCS), addressing the increasing prevalence and mortality of coronary artery disease (CAD) in China.

Area of Science:

  • Cardiology
  • Geriatrics
  • Internal Medicine

Background:

  • Coronary artery disease (CAD) prevalence and mortality are rising in China.
  • Chronic coronary syndrome (CCS) significantly impacts elderly patients, causing poor prognosis and substantial burdens.
  • High-risk CCS patients face elevated case fatality and mortality rates.

Purpose of the Study:

  • To standardize antithrombotic treatment for elderly patients with high-risk CCS.
  • To provide clinicians with evidence-based recommendations.
  • To address the growing health challenge of CAD in China's aging population.

Main Methods:

  • Development of a consensus by domestic experts from the Geriatrics Branch of the Chinese Medical Association.
  • Review of published clinical research evidence.
  • Consideration of relevant domestic and international guidelines, consensus statements, and expert recommendations.

Main Results:

  • The consensus offers standardized antithrombotic treatment strategies.
  • Recommendations are tailored for elderly patients with high-risk CCS.
  • The document serves as a clinical reference for healthcare providers.

Conclusions:

  • Standardized antithrombotic therapy is crucial for improving outcomes in high-risk elderly CCS patients.
  • This consensus aims to reduce mortality and enhance the quality of life for this demographic.
  • Effective management of CCS is essential for mitigating the economic and disease burden of CAD in China.

Keywords:
antithrombotic drugschronic coronary syndromecoronary artery disease

More Related Videos

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.1K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

471

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
19
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
18
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
27
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
12
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
14